Source link : https://newshealth.biz/health-news/ema-greenlights-aucatzyl-for-adult-all/
At its May 2025 meeting, the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) gave a conditional marketing authorization in the European Union for obecabtagene autoleucel (Aucatzyl) to treat adults from 26 years of age with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (B ALL). A conditional marketing authorization is […]
The post EMA Greenlights Aucatzyl for Adult ALL first appeared on News Health.
—-
Author : News Health
Publish date : 2025-05-23 14:32:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8